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A 35-year-old South African entrepreneur 
firmly believes he can revolutionise the local 
alcohol and drug testing market through 
gold standard hair testing technology that 
provides up to three months (and often 
more) of accurate abuse history.
What it requires, he told Izindaba, is 
for government policy and legislation to 
catch up with science and emulate other 
countries where his technology is widely 
used, enhancing judicial rulings across a 
host of fields. Not only could drunk or drug-
taking drivers (the latter for whom no legally 
enforceable test exists locally) be accurately 
and quickly tested, but drug abusers in 
rehabilitation, parents or guardians with 
alcohol and drug dependencies and 
prospective adoptive parents could also be 
checked for historical abuse.
Using a 381 mm (half inch)  length of 
hair, the analysis evaluates the number of 
drug metabolites imbedded inside the hair 
shaft (via sweat) – with every 381 mm of hair 
providing a 30-day history of drug or alcohol 
usage. Body hair is equally effective, making 
a total (and very close) body shave necessary 
to avoid detection. Shampooing or rigorous 
hair washing has little or no effect on results. 
Evidential snapshots from blood and liver 
function tests frame only a few days at best.
Legal fraternity latch on
Already lawyers in the United Kingdom 
and Germany are using Gauteng-born Avi 
Lasarow’s technology to shore up their cases 
in custody battles, social welfare matters 
and drunk and drug-driving trials, while its 
application in the long-term monitoring of 
addicts to see if they have stayed ‘clean’ has 
proved invaluable. Adoption testing – where 
prospective parents are tested as part of their 
suitability criteria – is also catching on fast, 
while German authorities are using it as part 
of their criteria for motorists who re-apply 
for (suspended) drivers’ licences. There are 
currently an estimated 20 000 hair alcohol 
and drug tests requested annually in UK 
child custody cases.
Two areas of application in South Africa 
excite Lasarow, whose company Trimega 
Labs can also check for the presence of 
the five most popular recreational drugs in 
a person’s hair. The first is antiretrovirals 
(ARV) compliance (and abuse), and the 
second is fetal alcohol syndrome (FAS). 
South Africa has the world’s greatest 
prevalence of both AIDS and FAS. A single 
test of a person living with AIDS can show if 
they have remained compliant over the past 
year (there are increasing reports of ARV 
users selling their drugs to merchants who 
mix them into a drug cocktail), and would 
be a world first. The contribution of such a 
test to the fight against drug-resistant strains 
of both HIV and TB would be huge, not to 
mention the verification and efficacy boost 
for patient drug compliance.
When it comes to FAS, Lasarow 
speaks passionately, arguing the case for 
philanthropic profit-making with ease 
and eloquence. Not only does he want to 
use his tests to monitor pregnant mothers 
(the Medical Research Council (MRC) is 
busy testing 600 pregnant women in pilot 
research), but he wants to analyse the infant’s 
meconium for indicators of FAS within the 
first week and thus enable rapid intervention 
within a fortnight.
Homeboy’s patriotic goals
His current goal is to ‘exit myself out of 
my UK company and take the extra funds 
I generate there to start working heavily 
in South Africa’. This is not just a pipe 
dream or solo entrepreneurial objective. He’s 
been heavily involved in political projects, 
partnering with the ANC and sponsoring 
that party’s initiatives to repatriate skills to 
South Africa for several years. Lasarow is a 
pivotal member of the Progressive Business 
Forum in London and a regular keynote 
speaker at the Homecoming Project and 
the South African Business Club. Last year 
he won the inaugural SA Business Award 
in London.
He explains his approach thus: ‘About 
three years ago I was at the pre-manifesto 
launch of Jacob Zuma in Bloemfontein. 
Everyone was singing struggle songs and 
the hair stood up on the back of my neck 
– I realised how lucky I was to watch the 
emergence of a democracy. That’s when I 
saw the opportunity to catch the vote of 
South Africans abroad. I can speak to those 
who “ran away” about my experience as an 
independent entrepreneur’.  Lasarow speaks 
proudly of a new ANC branch forming 
in London which he believes will have 
the ‘highest percentage of minority group 
members anywhere’.
In February this year he opened a R12 
million laboratory in Manchester that will 
provide world-class hair substance abuse 
testing and begin research into a hair test 
for ARV compliance. He’s confident this will 
soon result in protocols that can be tested in 
the field locally. Lasarow said patients with 
AIDS were being ‘mugged and robbed of 
their ARVs’, which were smoked in a dagga 
cocktail, while other desperately poor patients 
were selling their pills to make money.
Commercialising science to 
uplift populations
The young entrepreneur has no formal 
qualifications but partners with top scientists, 
using his razor-sharp intellect to translate 
research into marketable technology. He’s 
no stranger to failure, having made and lost 
a fortune in DNA testing when one of his 
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shareholders, the blind British former social 
security minister, David Blunkett, became 
embroiled in a paternity scandal six years 
ago.1 Fleet Street newspapers had a rollicking 
time when they found out that Blunkett, 
who wrote the foreword to Lasarow’s book, 
Who is Really Who? – A Comprehensive 
Guide to Paternity Testing, had also failed to 
disclose to parliament his shares in Lasarow’s 
company. Blunkett’s name has since entered 
popular culture in Britain, being thrice-
portrayed in dramatic or musical form, 
one such being ‘Who’s the Daddy?’ The 
Sheffield Blind Institute in his home town 
even began a local club night, called ‘The 
Electric Blunkett’.
Blunkett and Lasarow’s paternity 
testing business partnership was no mere 
coincidence. Both fought and won battles 
to prove their paternity to children born of 
former partners, an experience so traumatic 
for Lasarow that he vowed to come up 
with a less painful bio-scientific and simpler 
manner of verification – and thus made his 
first brief-lived fortune.
Lasarow liquidated his company, DNA 
BioScience, then picked himself up, working 
with a handful of loyal colleagues, ‘from a 
room no bigger than a broom cupboard’ at 
the Old Bailey in London, where he began 
exploring hard drug testing. The UK Office 
of Science and Technology soon pronounced 
hair drug testing as the gold standard because 
of its long window of evidence – and the 
courts followed suit. Child custody cases 
were at first Lasarow’s mainstay because of 
the UK courts’ reluctance to place children 
in mainstream childcare facilities (with all 
their negative and often criminal outcomes), 
making permanent caregivers (or parents) 
the favoured option. This put parental/
caregiver suitability on top of the checklist – 
and placed Lasarow’s drug hair testing centre 
stage, ahead of liver function and blood tests 
(complementing but not replacing them).
Restore law enforcement 
credibility
Shown a snapshot of South Africa’s 
gruesome alcohol-related statistics, Lasarow 
said the notorious backlogs in the country’s 
blood testing laboratories (read National 
Health Laboratory Services), needed urgent 
addressing to restore law enforcement 
credibility.
‘I’d try and work with legislation to allow 
third party labs to do these tests and implement 
a fast and efficient lab to shorten the whole 
customer journey,’ he said. Another wide 
open pasture of entrepreneurial endeavour 
locally would be drug and alcohol hair 
testing pre-driver-licensing and improved 
regular testing of long-distance drivers and 
airline pilots. ‘Basically policy and legislation 
need to be tightened up to catch up so we can 
start dealing with some of these social ills 
effectively,’ Lasarow concludes.
A Trimega poster to the Society of Hair 
Testing bi-annual conference resulted in 
consensus that the combined marker used by 
Lasarow’s company is the ‘marker of choice’. 
When blood and other tests are correlated 
with these results, most courts are able to 
rule beyond reasonable doubt.
Asked what his formula for success is, 
Lasarow says most people believe there are 
limitations to entrepreneurial success. ‘But 
you can upskill yourself on certain topics. 
I’ve been close to this for a long time and 
understand the technology. I know the 
markets exist and I’ve got a lead on it. I want 
to bring those skills back to South Africa.’
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As the hair grows, it absorbs special markers 
called fatty acid ethyl esters (FAEEs) and ethyl 
glucuronide (EtG) into its structure. While FAEE 
gets into the hair mainly by diffusion from an 
external sebum layer, EtG markers are formed 
almost exclusively in the liver and then deposited 
into hair mainly from sweat. The more markers 
there are, the more alcohol has been consumed.
Shown a snapshot of South 
Africa’s gruesome alcohol-related 
statistics, Lasarow said the 
notorious backlogs in the country’s 
blood testing laboratories (read 
National Health Laboratory 
Services), needed urgent 
addressing to restore law 
enforcement credibility.
Using a small sample of hair cut from the scalp, 
hair analysis evaluates the number of drug meta- 
bolites embedded inside the hair shaft. When 
compared with more traditional forms of testing 
(i.e. urine testing), hair samples can detect a long- 
er period of drug use. With urine, most drugs 
are undetectable if urinalysis is carried out more 
than 2 - 3 days after use, with the exception of 
cannabis, which may be detected for slightly 
longer periods of time.
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